Study of an experimental cell therapy for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests an investigative cell treatment called RGB-5088 for people with type 2 diabetes who need insulin. The goal is to see if it is safe and can help improve blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have had type 2 diabetes for at least 5 years
- Your weight falls within a certain range (body mass index between 18 and 30)
- Your blood sugar levels are within a specific range (HbA1c 7-10%)
- You are currently using insulin and are dependent on it
- You are willing to follow diet and exercise guidelines during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called RGB-5088 in people with type 1 diabetes. It aims to see if the treatment is safe and if it helps control blood sugar.
This trial tests if a type of stem cell product (exosomes) can safely and effectively help people with type 2 diabetes. Researchers will give infusions to see if it improves blood sugar control and pancreatic function.
This trial tests a new medication called BGM0504 for people with type 2 diabetes that is not well managed with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.
This study tests an experimental tablet to see if it can help control blood sugar in people with type 2 diabetes. It may be an option for those who are already on metformin or managing with diet and exercise.
This trial tests an experimental insulin (GZR101-80) to see if it helps control blood sugar in people with type 2 diabetes. You may join if you’ve had type 2 diabetes for at least 6 months and are between 18 and 75 years old.
This trial tests a new stem cell treatment (DT2-SCT) for people with type 2 diabetes who need insulin. It aims to see if the treatment is safe and helps control blood sugar better than a placebo.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.